Bibliographic Details
| Title: |
Incidencia, prevalencia y mortalidad del cáncer ovárico en Aragón: estimativas y proyecciones para el período de 1998 a 2022. |
| Alternate Title: |
Incidence, Prevalence and Mortality of Kidney Cancer in Spain: Estimates and Projections for the 1998 to 2022 Period. |
| Authors: |
Del Ser, Mercedes Calleja1, Corella Aznar, Elena Guadalupe1, Pérez, Milagros Bernal1 Mibernal@unizar.es |
| Source: |
Medicina Naturista. jul-dic2012, Vol. 6 Issue 2, p109-116. 8p. |
| Subjects: |
OVARIAN cancer prevention, OVARIAN cancer treatment, RENAL cancer, CANCER-related mortality, DISEASE incidence, DISEASE prevalence |
| Geographic Terms: |
SPAIN |
| Abstract (English): |
Objective: To estimate ovarian cancer incidence and prevalence in Aragon, based on mortality and survival data from the period 1998-2008, and to provide projections of incidence, prevalence and mortality until the year 2022. Material and methodology: All-cause and ovarian-cancer mortality rates were obtained from the National Statistics Institute and survival data were obtained from the EUROCARE study. Estimations were carded out using the MIAMOD program. The Joinpoint program was used to quantify the expected annual change in the projections. Results: An decrease in the incidence rate is expected in women from, this going from 18.6 (Adjusted Rate - AR = 9.2) per 100,000 inhabitants/year to 14.26 (AR = 6.83). Prevalence would decrease from 205.99 (AR = 51.62) to 168.03 (AR = 59.57), and mortality would decrease from 9.2 (AR = 6.02) to 6.83 (AR = 3.98) cases per 100.000 inhabitants/year. Conclusion: The projections indicate that ovarian cancer in Aragon follows an decreasing trend in incidence, mortality and prevalence. This needs to be considered in order to analyze the causes related to plan prevention and treatment that could have a positive effect on it. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): |
Objetivos: Estimar la incidencia y la prevalencia del cáncer de ovario en Aragón basándose en datos de mortalidad y supervivencia del período de 1998 a 2008 y proporcionar proyecciones de incidencia, prevalencia y mortalidad hasta el año 2022. Material y metodología: La mortalidad por todas las causas y para el cáncer de ovario se obtuvo del Instituto Nacional de Estadística y los datos de supervivencia del estudio EUROCARE. Las estimaciones han sido realizadas utilizando el programa MIAMOD. El programa Joinpoint ha sido utilizado para cuantificar el cambio anual que se espera en las proyecciones. Resultados: En mujeres se espera un descenso de la tasa de incidencia de 18,6 (tasa ajustada [TA] = 9,2) casos por 100.000 habitantes/año a 14,26 (TA = 6,83). La prevalencia disminuiría de 205,99 casos por 100.000 habitantes (TA = 51,62) a 168,03 (TA = 59,57) y la mortalidad de 9,2 (TA = 6,02) a 6,83 (TA = 3,98). Conclusiones: Las proyecciones indican que el cáncer ovárlco en Aragón sigue una tendencia de descenso en la incidencia, mortalidad y prevalencia, que necesitan ser consideradas para analizar las posibles causas en cuanto a medidas de prevención y tratamiento que pueden haber tenido un efecto positivo en ello. [ABSTRACT FROM AUTHOR] |
|
Copyright of Medicina Naturista is the property of Sociedad Europea de Medicina Naturista Clasica (Seccion Espanola) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
